Literature DB >> 210915

Opiate properties of SKF 525A.

T K Ho, F S LaBella, C Pinsky.   

Abstract

SKF 525A, a classical inhibitor of microsomal drug-metabolizing enzymes, is structurally similar to the diphenylpropylamine analgesics, and certain reported effects in animals resemble those produced by opiate drugs. In an opiate radioreceptor assay, SKF 525A was 50 times less potent than methadone in the absence of sodium and 10 times less potent in the prescence of sodium. The nature of the sodium effect indicates SKF 525A to have less opiate agonist character than does methadone. In mice, 2 mg of SKF 525A given intraperitoneally induced less profound analgesia on a hot plate (44 degrees C) than did 0.1 mg of methadone. Analgesia by SKF 525A was prevented by pretreatment of the mice with naloxone. In rats, 50 microgram of SKF 525A given intracerebroventricularly was analgesic.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 210915     DOI: 10.1139/y78-088

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  2 in total

1.  SKF-525A on schedule-controlled responding: not antagonized by naloxone.

Authors:  J D Leander
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

2.  CC12, a high-affinity ligand for [3H]cimetidine binding, is an improgan antagonist.

Authors:  Lindsay B Hough; Julia W Nalwalk; James G Phillips; Brian Kern; Zhixing Shan; Mark P Wentland; Iwan J P de Esch; Elwin Janssen; Travis Barr; Rebecca Stadel
Journal:  Neuropharmacology       Date:  2007-01-20       Impact factor: 5.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.